NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/05/2025
Back to search
Official data from USPTO
ARL BIO PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
05/06/2025
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
11/01/2017
Registration date
01/29/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2025
Last transaction
05/06/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
01/15/2017
First use in commerce
02/15/2017
Drawing code
3
Owner type
03
Owner location
Oklahoma City, OK
Examiner
GOODWIN, KATRINA
Current location
Historical data usage
Mark description
The mark consists of the letters "ARL" in uppercase, with the stem of the "R" incorporating a modified circle with a square corner in the top right quarter immediately above a test tube with graduation marks, all subscribed by the words "BIO PHARMA" in uppercase, centered from left to right.
Holders and representatives
Holders
ARL Bio Pharma, Inc.
Representatives
Randall K. McCarthy Hall Estill Hardwick Gable Golden & Nelson, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Laboratory research services and contract research servicesanalytical and microbiological testing for others in the pharmaceutical industry; Laboratory analysis for others in the pharmaceutical industry in the field of pharmaceuticals; Laboratory services in the fields of pharmacologymicrobiologytoxicologybiotechnology; Laboratory analysis services for pharmaceutical manufacturersbulk and raw material manufacturerscompoundinghospitalhealth system pharmacies industrylaboratory analysis in the field of pharmaceuticals; Testing and analysis of pharmaceuticals per industry standards and for compliance with the requirements of the United States Pharmacopeia regulatory requirements; Quality control testing for others in the pharmaceutical industry; Quality management servicesquality evaluation and analysisquality assurancequality controlin the fields of pharmacologymicrobiologytoxicologybiotechnology; Laboratory analysis services for the purpose of determining the identitypuritypotency and stability of pharmaceutical compounds; Testing of pharmaceutical raw materials to determine conformity with established regulatory standards; Development of scientific analytical and microbiological methods; Compatibility studies in the nature of testing to determine if mixing of pharmaceutical formulations affects their physical or chemical properties; Drug diversion testing in the nature of testing to confirm the identity of a pharmaceutical in a sampleto identify the presence in a sample of an unknown pharmaceuticalto determine the concentration of a pharmaceutical in a sample; Complaint sample testinganalytical and microbiological testing of a sample to determine the presencequality and concentration of pharmaceuticals; Laboratory serviceschemical and biological analysis for forensic purposes; Consulting services in the fields of scientific analysis and microbiological testing; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenomicsforensic science; Laboratory research services relating to pharmaceuticals
Publications
History of USPTO decisions and trademark events.
31 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/05/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/05/2025
E815
TEAS SECTION 8 & 15 RECEIVED
01/16/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/29/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/29/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/13/2018
PUBO
PUBLISHED FOR OPPOSITION
11/13/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/24/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/24/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
09/11/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/11/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
09/11/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/21/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/20/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/20/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/08/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/08/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/21/2018
GNRT
NON-FINAL ACTION E-MAILED
02/21/2018
CNRT
NON-FINAL ACTION WRITTEN
02/21/2018
DOCK
ASSIGNED TO EXAMINER
02/13/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/10/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2017
NWAP
NEW APPLICATION ENTERED
11/04/2017
Continuous trademark protection
Get notified about every new filing that threatens ARL BIO PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.